Quantum BioPharma Ltd (NASDAQ: QNTM) is 127.72% higher on its value in year-to-date trading and has touched a low of $2.70 and a high of $46.87 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The QNTM stock was last observed hovering at around $6.95 in the last trading session, with the day’s gains setting it 1.43%.
Currently trading at $8.38, the stock is 52.98% and 40.18% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 20.58% at the moment leaves the stock 38.56% off its SMA200. QNTM registered -80.77% loss for a year compared to 6-month gain of 114.32%. The firm has a 50-day simple moving average (SMA 50) of $5.9779 and a 200-day simple moving average (SMA200) of $6.04843.
The stock witnessed a 45.23% loss in the last 1 month and extending the period to 3 months gives it a 161.06%, and is 24.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.35% over the week and 18.12% over the month.
Distance from 52-week low is 210.37% and -82.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.42%).
10.0 institutions hold shares in Quantum BioPharma Ltd (QNTM), with institutional investors hold 16.76% of the company’s shares. The shares outstanding are 1.86M, and float is at 1.59M with Short Float at 3.09%. Institutions hold 14.84% of the Float.
